NOVARTIS VACCINES AND DIAGNOSTICS S.R.L. - Italy 

Ranking results:

Past rankings:

2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
Networking Rank (Reputation):> 1000
Partner Constancy:100-200
Project Leadership Index:73
Diversity Index:200-300
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:600-700
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:500-600
Total Number of Projects:700-800
Total Project Funding:200-300
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:700-800
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:300-400
Total Number of Projects:900-1000
Total Project Funding:400-500
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 10
As coordinator: 1
As participant: 5
Sole participant: 4
Coordinator / Participant Ratio: 0.2*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2015 168.277 0 168.277 1
2014 1.384.417 7.287.900 1.641.051 3 2
2013 179.740 2.742.146 983.652 1 1
2012 0 9.060.468 1.540.052 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
EUROPEAN VACCINE INITIATIVE EEIG1
EXTERNAUTICS1
HADASSAH MEDICAL ORGANIZATION1
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE1
INSTITUT PASTEUR1
INTERCELL1
LEIDEN UNIVERSITY MEDICAL CENTER1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
OKAIROS1
OXFORD BIOMEDICA PLC1
UNIVERSIDAD AUTONOMA DE MADRID1
UNIVERSITA DEGLI STUDI DI SIENA1
UNIVERSITE DE LAUSANNE1
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI1
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK1
UNIVERSITY COLLEGE LONDON1
VALNEVA AUSTRIA1
VIB1

Constancy:

Total number of partners: 23
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 20
Frequent / Rare Partner Ratio: 0.15

Project overview:

Start dateProjectacronymrolefundingpartners
2015-06-15Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy SVNanoVaxcoordinator168.2771
2014-10-01Vaccines and Imaging Partnership VIPparticipant1.287.9003
2014-04-01A multidisciplinary Doctoral Industrial School on novel preventive strategies against E. Coli infections DISCOcoordinator1.009.5872
2014-04-01Improving Prostate Cancer Outcome with Vectored Vaccines IMPROVEparticipant6.000.0005
2014-04-01Self-amplifying RNA technology applied to the development of a universal influenza vaccine SAMUFLUcoordinator187.4151
2014-03-01Structural Vaccinology to drive the design and optimization of protein antigens for a multicomponent vaccine against Staphylococcus aureus SV-STAPH-VAXcoordinator187.4151
2013-09-01Regulation of Expression of Staphylococcus aureus Vaccine Antigen Candidates RESTAVACcoordinator179.7401
2013-04-01Host-microbe interactions in health and disease. Interface with the immune system HOMINparticipant2.742.1465
2012-11-01Training network for next generation vaccinologists VACTRAINparticipant3.060.4689
2012-10-01A Multi-Stage Malaria Vaccine MULTIMALVAXparticipant6.000.0005

Alias institution names:

  • NOVARTIS VACCINES AND DIAGNOSTICS